360° SearchNetwork Hot Spots Trends Time Series

Ion Channel

Type: Keyphrase

Name: Ion Channel

First reported 23 hours ago - Updated 23 hours ago - 1 reports

Biophysical Research: Indiana University-Purdue University Reports Findings in Biophysical Research

Today's Medical & Research NewsBiophysical Research2013 MAY 18 -- By a News Reporter-Staff News Editor at Life Science Weekly -- A new study on Biophysical Research is now available. According to news reporting originating in Indianapolis, Indiana, by ... [Published NewsRX - 23 hours ago]

Entities: Biophysics, Ion, Indiana (United States), Hydrophobic, Ion Channel

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Extramembrane Control of Ion Channel Peptide Assemblies, Using Alamethicin as an Example

Accounts of Chemical Research DOI: 10.1021/ar4 ... [Published Accounts of Chemical Research - May 16 2013]

Entities: Ion Channel, Peptide, Chemical

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Zalicus Q1 net loss decreases

Zalicus Inc., a biopharmaceutical company, has reported that net loss for the first quarter ended March 31, 2013 was $8.05 million, or $0.06 loss per share, compared to a net loss of $13.54 million, or $0.13 loss per share, for the same quarter ended ... [Published Individual.com - May 16 2013]

Entities: Zalicus Inc, Ion Channel, Calcium channel blocker

First reported May 15 2013 - Updated May 15 2013 - 1 reports

Zalicus Posts Data on Novel, Oral, N- and T-Type Calcium Channel Blockers for the Treatment of Pain

Zalicus Inc. announced that preclinical data highlighting its novel, oral ion channel programs for the treatment of pain including Z160, an N-type calcium channel blocker and Z944, a T-type calcium channel blocker were presented at the 32nd Annual Scientific ... [Published Individual.com - May 15 2013]

Entities: Zalicus Inc, Calcium channel blocker, Calcium Channel Blockers

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Zalicus Reports Financial Results for the First Quarter 2013

By a News Reporter-Staff News Editor at Biotech Week -- Zalicus Inc. (Nasdaq Capital Market: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, reported financial results for the first quarter ... [Published Equities.com - May 08 2013]

Entities: Zalicus Inc, Ion Channel, Calcium channel blocker

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Global Ion Channel Modulators Industry

This report analyzes the worldwide markets for Ion Channel Modulators in US$ Million.The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts ... [Published Zecco - May 08 2013]

Entities: Ion Channel, market analysis, Analytics

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Ion Channel Modulators - Global Strategic Business Report - 2013-2018

Research and Markets (http://www.researchandmarkets.com/research/vstxdj/ion_channel) has announced the addition of the "Ion Channel Modulators - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for ... [Published Individual.com - May 08 2013]

Entities: Ion Channel, Japan, Zilog Inc, Convergence Pharmaceuticals Ltd

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Single Ion Channel Recordings with CMOS-Anchored Lipid Membranes

We present single-ion-channel recordings performed with biomimetic lipid membranes which are directly attached to the surface of a complementary metal–oxide–semiconductor (CMOS) preamplifier chip. With this system we resolve single-channel currents from ... [Published Nano Letters - May 08 2013]

Entities: Ion Channel, CMOS, Membranes, Lipid, Multiplexer

First reported May 04 2013 - Updated May 04 2013 - 1 reports

In situ Tip-Recordings Found No Evidence for an Orco-Based Ionotropic Mechanism of Pheromone-Transduction in Manduca sexta

by Andreas Nolte, Nico W. Funk, Latha Mukunda, Petra Gawalek, Achim Werckenthin, Bill S. Hansson, Dieter Wicher, Monika StenglThe mechanisms of insect odor transduction are still controversial. Insect odorant receptors (ORs) are 7TM receptors with inverted ... [Published Elites TV - May 04 2013]

Entities: Manduca sexta, Transduction, Ion Channel, Pheromone, Insect

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Outsourced Ion Channel Primary Screening Trends & 2015 Forecast in New Market Research Report at ReportsnReports.com

This market report summarizes the results of global web-based benchmarking survey on outsourced ion channel testing carried out in April 2013. The full report provides the data, details of the breakdown of the responses for each question, its segmentation ... [Published Bio-Medicine - May 03 2013]

Entities: Ion Channel, Cell Lines, Benchmarking, Profiling

First reported May 03 2013 - Updated May 03 2013 - 2 reports

Outsourced Ion Channel Primary Screening Trends & 2015 Forecast in New Market Research Report at ReportsnReports.com

“Outsourced Ion Channel Testing Trends 2013” is the new market research report added to ReportsnReports.com store. This market report summarizes the results of global web-based benchmarking survey on outsourced ion channel testing carried out in April ... [Published PRWeb - May 03 2013]

Entities: Ion Channel, Profiling, Cell Lines, Liability

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Zalicus Reports Financial Results for the First Quarter 2013

Home » Press Releases » Zalicus Inc. (Nasdaq Capital Market: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today reported financial results for the first quarter ended March 31, 2013 ... [Published BioPortfolio - May 02 2013]

Entities: Zalicus Inc, Ion Channel, Calcium channel blocker

Quotes

According to the news reporters, the research concluded: "The molecular character and phase behavior of water should thus be included in quantitative descriptions of ion channel gating."

Biophysical Research: Indiana University-Purdue University Reports Findings in Biophysical Research [Published NewsRX - 23 hours ago]

...to broaden and extend exclusivity for our ion channel programs Z160 and Z944," commented Mark H N Corrigan, MD, President and CEO of Zalicus. "Our primary focus is on advancing the development of our ion channel programs, including Z160, our first-in-class, oral N-type calcium channel blocker for the treatment of chronic neuropathic pain that is currently actively enrolling two Phase II clinical trials, and Z944, a novel oral T-type calcium channel blocker that is continuing to progress in the clinic."

Zalicus Q1 net loss decreases [Published Individual.com - May 16 2013]

In a poster presentation entitled "Z944: A first in-class T-type calcium channel blocker effective in nonclinical models of acute and inflammatory pain" Glenn F Short III, PhD, Senior Director of Research at Zalicus, presented preclinical data demonstrating that Z944:

Zalicus Posts Data on Novel, Oral, N- and T-Type Calcium Channel Blockers for the Treatment of Pain [Published Individual.com - May 15 2013]

...Her elderly mother's knee pain, arising from a fall, was relieved in minutes so she could walk on it again. "The combination of detoxification herbs and the micro-current frequencies provides lasting relief" , says Ms Candee...

Master Herbalist Andrea Candee Offers New Options for Pain Resolution... [Published PRWeb - May 14 2013]

More Content

sort by: Date \| Relevance
Biophysical Research: Indiana University-Purdue... [Published NewsRX - 23 hours ago]
Extramembrane Control of Ion Channel Peptide As... [Published Accounts of Chemical Research - May 16 2013]
Zalicus Q1 net loss decreases [Published Individual.com - May 16 2013]
Zalicus Posts Data on Novel, Oral, N- and T-Typ... [Published Individual.com - May 15 2013]
Induced pluripotent stem cells in high-throughp... [Published Drug Discovery World - May 14 2013]
Master Herbalist Andrea Candee Offers New Optio... [Published PRWeb - May 14 2013]
Does Cell Therapy Hold The Key To Treating Stroke? [Published Seeking Alpha - May 13 2013]
Zalicus Inc. (ZLCS) Presents Data on Novel, Ora... [Published BioSpace - May 10 2013]
Zalicus Presents Data on Novel, Oral, N- and T-... [Published Business Wire - May 10 2013]
Researchers identify how cells control calcium ... [Published UC Newswire - May 08 2013]
Zalicus Reports Financial Results for the First... [Published Equities.com - May 08 2013]
Global Ion Channel Modulators Industry [Published Zecco - May 08 2013]
Global Ion Channel Modulators Industry [Published PR Newswire: General Business - May 08 2013]
Extracellular pH and Neuronal Depolarization Se... [Published Journal of Neuroscience - May 08 2013]
Lincoln Park Backs Publicly Traded Zalicus [Published PE Hub News - May 08 2013]
Zalicus Secures New $25 Million Funding Commitm... [Published NewsBlaze - May 08 2013]
Research and Markets: Ion Channel Modulators - ... [Published Business Wire Health News - May 08 2013]
Research and Markets: Ion Channel Modulators - ... [Published Business Wire Manufacturing News - May 08 2013]
Ion Channel Modulators - Global Strategic Busin... [Published Individual.com - May 08 2013]
Single Ion Channel Recordings with CMOS-Anchore... [Published Nano Letters - May 08 2013]
Genetic Research: Researchers at National Insti... [Published NewsRX - May 05 2013]
Market Report, "Anesthetic Effect - Pipeline Re... [Published Live-PR.com - May 05 2013]
In situ Tip-Recordings Found No Evidence for an... [Published Elites TV - May 04 2013]
Outsourced Ion Channel Primary Screening Trends... [Published Bio-Medicine - May 03 2013]
Outsourced Ion Channel Primary Screening Trends... [Published PRWeb - May 03 2013]
2013 Outsourced Ion Channel Testing Market [Published Zunia.org RSS - May 03 2013]
Research and Markets: Neuroprotection - Drugs, ... [Published Yahoo! Finance - May 02 2013]
Research and Markets: Neuroprotection - Drugs, ... [Published Business Wire - May 02 2013]
Fibromyalgia Study Suggests Muscles Are 'Wired ... [Published Pro Health Network - May 02 2013]
Neuroprotection - Drugs, Markets and Companies ... [Published Individual.com - May 02 2013]

Blogs

sort by: Date \| Relevance
2013 Outsourced Ion Channel Testing Market [Published Zunia.org RSS - May 03 2013] This market report summarizes the results of HTStecs industry-wide global web-based benchmarking survey on outsourced ion channel testing carried out in April 2013. The study was initiated by HTStec as part of its ongoing tracking of emerging life science ...
Ion Channel Releases ATP for Taste Perception [Published NIGMS Biomedical Beat - Apr 18 2013] The sense of taste consists of five primary types: sweet, sour, salt, bitter and umami (savory). Researchers have figured out how cells transmit information regarding three of these taste types. The involvement of ATP, the body’s main fuel source, was ...
Buzzworthy Catalysts Giving Juice to Dow 30 Hea... [Published Wall St. Cheat Sheet - Apr 07 2013] Pfizer ( NYSE:PFE ): Current price $29.09 Pfizer, Procter & Gamble ( NYSE:PG ), and Arm & Hammer owner Church & Dwight Co. ( NYSE:CHD ) all bought manufacturers of dietary supplements in 2012, and more such deals are expected, as companies gamble ...
4 Healthcare Stock Stories for Thursday Investm... [Published Wall St. Cheat Sheet - Apr 04 2013] HealthSouth Corp. ( NYSE:HLS ): Closing price $26.42 HealthSouth has purchased land, and expects to to build a new approximately 54,000-square foot inpatient rehabilitation hospital in Modesto. Connected with these plans, HealthSouth acquired 5.5 ...
Pfizer Tries Out New Technology and 4 Stocks At... [Published Wall St. Cheat Sheet - Apr 04 2013] Acuity Brands ( NYSE:AYI ): Closing price $71.84 Acuity Brands Chief Executive Vernon J. Nagel has commented that “third-party forecasts and leading indicators suggest that the North American lighting market will increase in the mid-single digits ...

Press Releases

sort by: Date \| Relevance
Zalicus Presents Data on Novel, Oral, N- and T-... [Published Business Wire - May 10 2013]
Global Ion Channel Modulators Industry [Published PR Newswire: General Business - May 08 2013]
Research and Markets: Ion Channel Modulators - ... [Published Business Wire Health News - May 08 2013]
Research and Markets: Ion Channel Modulators - ... [Published Business Wire Manufacturing News - May 08 2013]
Research and Markets: Neuroprotection - Drugs, ... [Published Business Wire - May 02 2013]